AU3345495A - Vaccines containing borrelia burgdorferi ospg - Google Patents

Vaccines containing borrelia burgdorferi ospg

Info

Publication number
AU3345495A
AU3345495A AU33454/95A AU3345495A AU3345495A AU 3345495 A AU3345495 A AU 3345495A AU 33454/95 A AU33454/95 A AU 33454/95A AU 3345495 A AU3345495 A AU 3345495A AU 3345495 A AU3345495 A AU 3345495A
Authority
AU
Australia
Prior art keywords
ospg
borrelia burgdorferi
vaccines containing
containing borrelia
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU33454/95A
Other versions
AU687620B2 (en
Inventor
Michael D Kramer
Markus M. Dr Simon
Reinhard Wallich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9416667A external-priority patent/GB9416667D0/en
Priority claimed from GBGB9503867.5A external-priority patent/GB9503867D0/en
Application filed by Deutsches Krebsforschungszentrum DKFZ, Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of AU3345495A publication Critical patent/AU3345495A/en
Application granted granted Critical
Publication of AU687620B2 publication Critical patent/AU687620B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
AU33454/95A 1994-08-17 1995-08-11 Vaccines containing borrelia burgdorferi OspG Ceased AU687620B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9416667 1994-08-17
GB9416667A GB9416667D0 (en) 1994-08-17 1994-08-17 Vaccines and diagnostics
GBGB9503867.5A GB9503867D0 (en) 1995-02-25 1995-02-25 Vaccines and diagnostics
GB9503867 1995-02-25
PCT/EP1995/003213 WO1996005313A1 (en) 1994-08-17 1995-08-11 VACCINES CONTAINING BORRELIA BURGDORFERI OspG

Publications (2)

Publication Number Publication Date
AU3345495A true AU3345495A (en) 1996-03-07
AU687620B2 AU687620B2 (en) 1998-02-26

Family

ID=26305468

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33454/95A Ceased AU687620B2 (en) 1994-08-17 1995-08-11 Vaccines containing borrelia burgdorferi OspG

Country Status (12)

Country Link
EP (1) EP0781338A1 (en)
JP (1) JPH10504455A (en)
KR (1) KR970705636A (en)
CN (1) CN1159831A (en)
AU (1) AU687620B2 (en)
BR (1) BR9508802A (en)
CA (1) CA2197712A1 (en)
CZ (1) CZ42497A3 (en)
HU (1) HUT77251A (en)
NZ (1) NZ291818A (en)
PL (1) PL318672A1 (en)
WO (1) WO1996005313A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19632862B4 (en) 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologically active proteins of Borrelia burgdorferi, nucleic acids coding for them as well as their use in test kits and as vaccines
MX2013003609A (en) * 2010-09-27 2013-10-17 Univ Cornell Methods for diagnosing lyme disease.
CN111196842A (en) * 2020-01-09 2020-05-26 济南大学 Expression and purification method of non-transmembrane structural domain of outer membrane transport channel protein

Also Published As

Publication number Publication date
CA2197712A1 (en) 1996-02-22
JPH10504455A (en) 1998-05-06
WO1996005313A1 (en) 1996-02-22
AU687620B2 (en) 1998-02-26
CZ42497A3 (en) 1997-10-15
HUT77251A (en) 1998-03-02
KR970705636A (en) 1997-10-09
NZ291818A (en) 1998-09-24
PL318672A1 (en) 1997-07-07
CN1159831A (en) 1997-09-17
BR9508802A (en) 1997-12-30
EP0781338A1 (en) 1997-07-02

Similar Documents

Publication Publication Date Title
AU696232B2 (en) Syringe
AU2218395A (en) Bone regeneration
AU4781297A (en) Vaccines
AU3152397A (en) Compositions and methods for administering BORRELIA DNA
AU5947894A (en) Knot pusher for videoendoscopic surgery
AUPM897594A0 (en) Controlled release container
AU6757994A (en) New adhesive compositions for surgical use
AU1806895A (en) Controlled release composition
AU1563495A (en) Adhesive surgical retaining device
AU5366496A (en) Plug-in multiplexer
AU4520196A (en) Force feedback for virtual reality
AU7577994A (en) Methods for inhibiting bone loss
AU2523895A (en) Protein-scum remover
PL313979A1 (en) Vaccine composition
PL316074A1 (en) Pusher unit
AU2923492A (en) Borrelia burgdorferi antigens and uses thereof
AU1226992A (en) Flagella-less borrelia
AU4434796A (en) Bone mass anabolic composition comprising olpadronate
AU1172097A (en) Pharmaceutical composition containing trehalose
AU4344996A (en) Vessel-puncturing cannula
AU3345495A (en) Vaccines containing borrelia burgdorferi ospg
AU4374893A (en) Cuspidor
GB9417807D0 (en) Virtual reality systems
AU7783894A (en) Vaccines and diagnostics for borrelia burgdorferi
AU1836097A (en) Borrelia burgdorferi outer membrane proteins